Wave Life Sciences selected as GSK transitions sIRNA program; $12 million milestone
Wave Life Sciences says it will receive a $12 million milestone payment for candidate selection and is eligible for up to $375 million in milestones per program plus tiered royalties after GSK selects the sIRNA program for further development.